Remission induction with lenalidomide alone in a patient with previously untreated plasmablastic myeloma

a case report.

Taimur Sher, Kena C. Miller, Kelvin Lee, Asher A Chanan Khan

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Multiple myeloma patients with plasmablastic morphology of tumor cells and extramedullary presentation of disease often have an aggressive clinical course and resistance to chemotherapy. We describe a case of an elderly patient who presented with extramedullary, IgA-lambda-secreting multiple myeloma with plasmablastic features who demonstrated impressive clinical response to single-agent lenalidomide. This is the first description of a plasmablastic variety of multiple myeloma successfully treated with lenalidomide alone.

Original languageEnglish (US)
Pages (from-to)328-330
Number of pages3
JournalClinical lymphoma & myeloma
Volume9
Issue number4
StatePublished - Aug 2009
Externally publishedYes

Fingerprint

Remission Induction
Multiple Myeloma
Immunoglobulin A
Drug Therapy
lenalidomide
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Remission induction with lenalidomide alone in a patient with previously untreated plasmablastic myeloma : a case report. / Sher, Taimur; Miller, Kena C.; Lee, Kelvin; Chanan Khan, Asher A.

In: Clinical lymphoma & myeloma, Vol. 9, No. 4, 08.2009, p. 328-330.

Research output: Contribution to journalArticle

@article{88d2714e628b40bdb92a741cb6cb637d,
title = "Remission induction with lenalidomide alone in a patient with previously untreated plasmablastic myeloma: a case report.",
abstract = "Multiple myeloma patients with plasmablastic morphology of tumor cells and extramedullary presentation of disease often have an aggressive clinical course and resistance to chemotherapy. We describe a case of an elderly patient who presented with extramedullary, IgA-lambda-secreting multiple myeloma with plasmablastic features who demonstrated impressive clinical response to single-agent lenalidomide. This is the first description of a plasmablastic variety of multiple myeloma successfully treated with lenalidomide alone.",
author = "Taimur Sher and Miller, {Kena C.} and Kelvin Lee and {Chanan Khan}, {Asher A}",
year = "2009",
month = "8",
language = "English (US)",
volume = "9",
pages = "328--330",
journal = "Clinical Lymphoma, Myeloma and Leukemia",
issn = "2152-2669",
publisher = "Cancer Media Group",
number = "4",

}

TY - JOUR

T1 - Remission induction with lenalidomide alone in a patient with previously untreated plasmablastic myeloma

T2 - a case report.

AU - Sher, Taimur

AU - Miller, Kena C.

AU - Lee, Kelvin

AU - Chanan Khan, Asher A

PY - 2009/8

Y1 - 2009/8

N2 - Multiple myeloma patients with plasmablastic morphology of tumor cells and extramedullary presentation of disease often have an aggressive clinical course and resistance to chemotherapy. We describe a case of an elderly patient who presented with extramedullary, IgA-lambda-secreting multiple myeloma with plasmablastic features who demonstrated impressive clinical response to single-agent lenalidomide. This is the first description of a plasmablastic variety of multiple myeloma successfully treated with lenalidomide alone.

AB - Multiple myeloma patients with plasmablastic morphology of tumor cells and extramedullary presentation of disease often have an aggressive clinical course and resistance to chemotherapy. We describe a case of an elderly patient who presented with extramedullary, IgA-lambda-secreting multiple myeloma with plasmablastic features who demonstrated impressive clinical response to single-agent lenalidomide. This is the first description of a plasmablastic variety of multiple myeloma successfully treated with lenalidomide alone.

UR - http://www.scopus.com/inward/record.url?scp=77449124102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77449124102&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 328

EP - 330

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

SN - 2152-2669

IS - 4

ER -